Participatory grant-making works!

women_riseParticipatory grant-making helps to shift power relations in Mexico.  Powerful results surfaced when a Mexican women’s rights funder began to give decision-making power to local activists.
By Jenny Barry

Recovering the values of feminist philanthropy

Fondo Semillas’ participatory grant-making journey started within the framework of a strategic planning, during a process to build consensus around our institutional values and principles as a grantmaker. To do so, we divided into working groups that included staff and board members, current and former grantees, and other key allies from the Mexican feminist movement. These groups highlighted values that are central to the fund’s feminist identity, such as shared power, inclusion, horizontality, and diversity. Through these conversations, we reflected on the extent to which our own practice of resourcing women’s rights mirrored these ideals. We agreed that it was imperative to pay closer attention to the politics of how our grant-making was carried out—who is included and excluded, what style of leadership is recognized, as well as how decisions are made and agendas set.

In our 27 years of funding women’s rights activism, we have learned that it is not our role to be prescriptive in our grant-making by pushing for specific policy changes. Rather, our experience is that these changes are the result of a strong feminist movement, which also plays a critical role in resisting setbacks and preserving previously-won victories for women’s rights. We soon realized that it was somewhat hypocritical to assert that grassroots women are the experts on the issues facing their communities, while not fully involving them in decisions regarding how to allocate funding to grassroots women’s groups. Previously, Fondo Semillas made grantmaking decisions with the support of small selection committees made up of staff and board members, as well as a few experts who were sometimes—but not always—former grantees. We decided that, in order to truly reflect our values, grassroots feminist activists had to play a much more central role in the decision-making process.

Defining participation

The term “participation” gets thrown around a lot without much clarity. Many different models of participatory grantmaking exist, some of which include representatives of certain movements or communities in grantmaking decisions, while others involve the applicants themselves.

With the support of current and former grantees and other feminist allies, Fondo Semillas reviewed existing models and ultimately decided to include two main forms of participation in its new selection process. First, Fondo Semillas hosted a forum with 40 diverse representatives of the Mexican feminist movement. Fondo Semillas selected the representatives based on their availability, knowledge of specific regional contexts, and areas of thematic expertise. After reviewing the organizational profiles of potential grantees, the forum participants engaged in small-group discussions regarding the status of feminist organizing in Mexico, first by region and then by thematic area.

Read moreParticipatory grant-making works!

Big Pharma Greed Kills Women!

Big Pharma Greed Kills Women!
Tomorrow more than 50 women living with cancer will join 500+ activists from the Treatment Action Campaign, Cancer Alliance, SECTION27, MSF, and other members of the Fix the Patent Laws coalition at a picket outside pharmaceutical company Roche. We will be highlighting our ongoing concerns over the excessive price of breast cancer medicine trastuzumab.

The picket will be in memory of Tobeka Daki. An activist who had been leading this call in 2016 but who sadly passed away without ever getting the chance to access trastuzumab.

In South Africa Roche holds multiple patents on trastuzumab (Herceptin) that may block more affordable biosimilars coming to market until 2033. Currently it costs around ZAR 211,920 for a year’s treatment course in the public sector and is only available in very limited circumstances. It is excluded from prescribed minimum benefits of private medical schemes because of the cost. Other developing countries face similar problems in accessing affordable trastuzumab.

In other parts of the world where the patents have expired, Roche is using different means to block access including litigating against biosimilar versions.

We stand with women with breast cancer and activists across the world to say “Roche Greed Kills”.

Read moreBig Pharma Greed Kills Women!